Events

Field Safety Notices about NC Trek RX Coronary Dilatation Catheter NC Traveler RX Coronary Dilatation Catheter - NC Trek RX Coronary Dilatation Catheter

According to Agence Fédérale des Médicaments et des Produits de Santé, this field safety notices involved a device in Belgium that was produced by Abbott Vascular.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Date
    2017-03-22
  • Event Country
    Belgium
  • Event Source
    AFMPS
  • Event Source URL
    https://www.afmps.be/fr/humain/produits_de_sante/dispositifs_medicaux/materiovigilance/fsn
  • Notes / Alerts
    Belgian data is current through November 2018. All of the data comes from the Federal Agency for Medicines and Health Products, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Belgium.
  • Extra notes in the data

Device

NC Trek RX Coronary Dilatation Catheter NC Traveler RX Coronary Dilatation Catheter - NC Trek RX ...

Manufacturer

Abbott Vascular
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    AFMPS